Latest News about CTLT
Recent news which mentions CTLT
Intra-Cellular Therapies Discloses New Drug Candidate For Dementia Related Episodes
February 24, 2021
From Benzinga
Should Investors Worry About Moderna's Vaccine Delays?
February 23, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March
February 16, 2021
From Motley Fool
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
February 03, 2021
From MarketWatch
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
Catalent Inc (CTLT) Q2 2021 Earnings Call Transcript
February 02, 2021
Tickers
CTLT
From Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
February 02, 2021
From Benzinga
The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment
February 02, 2021
From Benzinga
Earnings Scheduled For February 2, 2021
February 02, 2021
From Benzinga
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
January 30, 2021
From Benzinga
What Are Moderna's Risks?
January 24, 2021
From Motley Fool
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
January 13, 2021
From Benzinga
These are the best-performing Nasdaq and S&P 500 stocks of 2020
December 29, 2020
From MarketWatch
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Earnings, Economic Data
December 10, 2020
From Benzinga
Here’s how Tesla’s S&P 500 inclusion may play out
November 17, 2020
From MarketWatch
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 09, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 06, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
November 05, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 04, 2020
From Benzinga
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
November 03, 2020
From Benzinga
Earnings Scheduled For November 3, 2020
November 03, 2020
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
S&P 500 newcomer Teradyne’s Q3 sales up 41%
October 20, 2020
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.